Clinical OpportunitiesThe analyst remains optimistic that AKYA's performance will improve, with the company's clinical opportunity adding upside for the long term.
New Product LaunchAkoya remains confident it can return to revenue growth due to the launch of new products and a robust clinical trial pipeline.
Strategic AlternativesThe company is actively evaluating a range of strategic alternatives to identify the best path forward for sustainable growth, profitability, and long-term success.